[{"Assets_0_Q2_USD":21485900000.0,"EarningsPerShareBasic_2_Q2_USD":40.06,"EarningsPerShareBasic_1_Q2_USD":29.51,"EarningsPerShareDiluted_1_Q2_USD":27.97,"EarningsPerShareDiluted_2_Q2_USD":38.07,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1295200000.0,"NetIncomeLossConverted_2_Q2_USD":4214100000.0,"NetIncomeLossConverted_1_Q2_USD":3098900000.0,"RevenuesConverted_1_Q2_USD":5138500000.0,"RevenuesConverted_2_Q2_USD":7667200000.0,"StockholdersEquity_0_Q2_USD":15127300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":110700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":110800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":105000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":105200000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210805"}]